Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Min Huang, PhD

Sr. Principal Scientist
Merck & Co., Inc.

Disclosure(s): Merck & Co., Inc.: full-time employee

Poster(s):

578 - Cost-effectiveness of Infant Vaccination with PCV15 Compared to PCV13 in the United States
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET